Li Jongming, Melenhorst Jos, Hensel Nancy, Rezvani Katyoun, Sconocchia Giuseppe, Kilical Yasemin, Hou Jean, Curfman Blanche, Major Eugene, Barrett A John
Medical Oncology Division, Thomas Jefferson University, Philadelphia, PA, USA.
Hematology Branch, National Heart, Lung, Blood Institute, National Institutes of Health, Bldg 10 CRC, Room 3-5330, 10 Center Drive, Bethesda, MD 20892-1202, USA.
J Gen Virol. 2006 Oct;87(Pt 10):2951-2960. doi: 10.1099/vir.0.82094-0.
Infection with BK virus (BKV) induces both humoral and cellular immunity, but the viral antigens of T-antigen (T-ag) stimulating T-cell responses are largely unknown. To identify BKV-specific T cells in healthy individuals, peripheral blood lymphocytes were cultured with autologous dendritic cells (DCs) loaded with BKV lysate and T cells were screened for intracellular gamma interferon production after stimulation with an overlapping 15mer peptide library of the BKV T-ag. Among many immunogenic peptides identified, four T-ag peptides were identified as candidate major histocompatibility complex class I and II T-cell epitopes, restricted to human leukocyte antigen (HLA)-B0702, -B08, -DRB10301 and -DRB10901. Further, a candidate 9mer peptide, LPLMRKAYL, was confirmed to be restricted to HLA-B0702 and -B08. Because the polyomaviruses BKV, JC virus (JCV) and Simian virus 40 (SV40) share extensive sequence similarity in the immunogenic proteins T-ag and VP1, it was hypothesized that, in humans, these proteins contain conserved cytotoxic T-lymphocyte (CTL) target epitopes. Four HLA-restricted conserved epitopes of BKV, JCV and SV40 were identified: HLA-B07, -B08 and -DRB10901 for T-ag and -A0201 for VP1. T cells cultured in vitro that were specific for one viral antigen recognized other conserved epitopes. CTLs generated from BKV T-ag and VP1 peptide were cytotoxic to DC targets pulsed with either BKV or JCV. Therefore, infection by one of the two viruses (BKV and JCV) could establish cross-immunity against the other. Although cross-cytotoxicity experiments were not performed with SV40, cross-recognition data from conserved antigen epitopes of polyomaviruses suggest strongly that cross-immunity might also exist among the three viruses.
BK病毒(BKV)感染可诱导体液免疫和细胞免疫,但刺激T细胞反应的T抗原(T-ag)的病毒抗原在很大程度上尚不清楚。为了鉴定健康个体中BKV特异性T细胞,将外周血淋巴细胞与负载BKV裂解物的自体树突状细胞(DC)一起培养,并用BKV T-ag的重叠15聚体肽库刺激后筛选T细胞的细胞内γ干扰素产生。在鉴定出的许多免疫原性肽中,四种T-ag肽被鉴定为候选主要组织相容性复合体I类和II类T细胞表位,受限于人类白细胞抗原(HLA)-B0702、-B08、-DRB10301和-DRB10901。此外,一种候选9聚体肽LPLMRKAYL被证实受限于HLA-B0702和-B08。由于多瘤病毒BKV、JC病毒(JCV)和猴病毒40(SV40)在免疫原性蛋白T-ag和VP1中具有广泛的序列相似性,因此推测在人类中,这些蛋白含有保守的细胞毒性T淋巴细胞(CTL)靶表位。鉴定出了BKV、JCV和SV40的四个HLA限制性保守表位:T-ag的HLA-B07、-B08和-DRB10901以及VP1的-A0201。体外培养的对一种病毒抗原具有特异性的T细胞识别其他保守表位。由BKV T-ag和VP1肽产生的CTL对用BKV或JCV脉冲处理的DC靶细胞具有细胞毒性。因此,两种病毒(BKV和JCV)之一的感染可以建立针对另一种病毒的交叉免疫。虽然未对SV40进行交叉细胞毒性实验,但来自多瘤病毒保守抗原表位的交叉识别数据强烈表明,这三种病毒之间也可能存在交叉免疫。